Identification and validation of Parkinson's disease relevant microRNAs in plasma extracellular vesicles.
A simple blood test detecting specific molecules identifies Parkinson's disease before symptoms fully develop, supporting earlier diagnosis and monitoring.
Plasma extracellular vesicle-derived microRNAs are identified and validated as Parkinson's disease biomarkers, providing a minimally invasive liquid biopsy approach to PD diagnosis that may enable earlier detection of neurodegeneration before clinical symptoms become pronounced. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- Biomarker identification and clinical validation study in plasma extracellular vesicles (human blood samples)
- Category
- aging_longevity_population_health
- Maturity
- Validated
- Journal
- Neurological Sciences
Why it surfaced
Liquid biopsy approach for Parkinson's disease using EV-miRNA; bridges early-detection methodology to neurodegenerative disease; directly relevant to aging/longevity watchlist; Neurological Sciences publication.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.